TMC Life Sciences Berhad
0101
Rank in Stocks
#17129
TMC Life Sciences Berhad operates as an investment holding entity, specializing... TMC Life Sciences Berhad operates as an investment holding entity, specializing in the provision of healthcare services throughout Malaysia. Its primary asset is Thomson Hospital Kota Damansara (THKD), a substantial 559-bed medical facility located in Selangor. THKD delivers a comprehensive spectrum of medical specialties, including orthopedics, ear, nose, and throat (ENT) care, head and neck laser procedures, dedicated services for women and children, fertility treatments, dietetic guidance, and emergency care. The company's fertility centers offer advanced reproductive technologies such as time-lapse imaging, preimplantation genetic testing, and fertility genecode analysis, alongside expert consultancy services. Beyond its main hospital operations, TMC Life Sciences manages a network of women's clinics and fertility centers, provides laboratory and embryology services, traditional and complementary medicine, and operates pharmacy outlets. Its activities further extend to developing and marketing healthcare programs, offering multi-disciplinary tertiary care support, engaging in research and development initiatives, and undertaking property investments. Established in 1994 and based in Petaling Jaya, Malaysia, the company is a subsidiary of Sasteria (M) Pte. Ltd.
Share Price
$0.10349928
Last synced: 2026-11-06
Market Cap
$180.28M
Change (1 day)
0.14%
Change (1 year)
-0.38%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TMC Life Sciences Berhad (0101)
Category
Healthcare
Operating Margin for TMC Life Sciences Berhad (0101)
Operating Margin as of November 2026 TTM: 7.74%
According to TMC Life Sciences Berhad's latest financial reports, its current operating margin (TTM) is 7.74%. At the end of 2025 the company had an operating margin of 2.21%.
Operating Margin history for TMC Life Sciences Berhad from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.74% | 250.23% |
| 2025 | 2.21% | -86.13% |
| 2024 | 15.93% | 0.44% |
| 2023 | 15.86% | 14.02% |
| 2022 | 13.91% | 0.14% |
| 2021 | 13.89% | 53.31% |
| 2020 | 9.06% | -53.80% |
| 2019 | 19.61% | 0.26% |
| 2018 | 19.56% | 9.03% |
| 2017 | 17.94% | 74.85% |
| 2016 | 10.26% | 23.17% |
| 2015 | 8.33% | 6.93% |
| 2014 | 7.79% | 167.70% |
| 2013 | 2.91% | -130.09% |
| 2012 | -9.67% | -78.09% |
| 2011 | -44.14% | 199.66% |
| 2009 | -14.73% | -225.36% |
| 2008 | 11.75% | -71.69% |
| 2007 | 41.51% | -17.95% |
| 2006 | 50.59% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.34% | -98.02% |
US
|
|
| 9.60% | -98.76% |
DE
|
|
| 19.85% | -97.44% |
US
|
|
| 18.76% | -97.58% |
SA
|
|
| 6.10% | -99.21% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TMC Life Sciences Berhad's operating margin
What is TMC Life Sciences Berhad's operating margin?
TMC Life Sciences Berhad's operating margin is 7.74%, as of Nov 2026.
What was TMC Life Sciences Berhad's operating margin in 2025?
In 2025, TMC Life Sciences Berhad's operating margin was 2.21%, compared with 15.93% in 2024.
How has TMC Life Sciences Berhad's operating margin changed since 2020?
From 2020 to 2025, TMC Life Sciences Berhad's operating margin was highest in 2024 (15.93%) and lowest in 2025 (2.21%).
How does TMC Life Sciences Berhad's operating margin compare with similar companies?
TMC Life Sciences Berhad's operating margin (7.74%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with 19.85%.